Regeneron pharmaceuticals inc. articles
-
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Update
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) was the target of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 1,050,000 shares, a drop of 15.3% from the March 31st total of 1,240,000 shares. Based on an average trading volume of 341,300 shares, […]
-
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medi
-
Alphabet Inc. (NASDAQ:GOOG) Shares Acquired by Evolution Advisers Inc.
Evolution Advisers Inc. boosted its position in shares of Alphabet Inc. (NASDAQ:GOOG – Free Report) by 200.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 600 shares of the information services provider’s stock after buying an additional 400 shares during the […]